No results for ‘’
Crestchem Ltd
NSE: BSE: 526269
â‚ą134
(3.08%)
Mon, 14 Sept 2026, 06:36 am
Market Cap (in Cr)39.52
PE Ratio12.16
Dividend1.14
Health Technology
Pharmaceuticals: Other
24.5KCrestchem Analysis
dividend
- Unable to evaluate Crestchem's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Crestchem's dividend against the top 25% market benchmark as the company has not reported any payouts.
health
- Crestchem is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Crestchem is profitable, therefore cash runway is not a concern.
- Crestchem is profitable, therefore cash runway is not a concern.
- Debt is covered by short term assets, assets are 7.6x debt.
- Crestchem has no long term commitments.
- The level of debt compared to net worth has been reduced over the past 5 years (59.6% vs 37.9% today).
- Crestchem earns more interest than it pays, coverage of interest payments is not a concern.
- Crestchem's level of debt (37.9%) compared to net worth is satisfactory (less than 40%).
- Low level of unsold assets.
- Operating cash flow is negative therefore debt is not well covered.
management
- The tenure for the Crestchem board of directors is about average.
- Dipak's remuneration is lower than average for companies of similar size in India.
- Dipak's compensation has increased in line with Crestchem recently becoming profitable.
misc
- Crestchem is not covered by any analysts.
- BSE:526269 has not traded for 8 days.
past
- Crestchem used its assets more efficiently than the IN Chemicals industry average last year based on Return on Assets.
- Crestchem has become profitable over the past 3 years. This is considered to be a significant improvement in its use of capital (Return on Capital Employed).
- Crestchem has efficiently used shareholders’ funds last year (Return on Equity greater than 20%).
- Crestchem has become profitable in the last year making the earnings growth rate difficult to compare to the 5-year average.
- Crestchem's year on year earnings growth rate was negative over the past 5 years, however the most recent earnings are above average.
- Crestchem has become profitable in the last year making it difficult to compare the IN Chemicals industry average.
value
- Crestchem is overvalued based on assets compared to the IN Chemicals industry average.
- Crestchem is overvalued based on earnings compared to the IN Chemicals industry average.
- Crestchem is overvalued based on earnings compared to the India market.
- 526269 underperformed the Chemicals industry which returned 2.2% over the past year.
- 526269 underperformed the Market in India which returned -14.5% over the past year.
- BSE:526269 is flat (0%) underperforming the Chemicals industry which returned 6.9% over the past month.
- BSE:526269 is flat (0%) underperforming the market in India which returned 8% over the past month.